Positron emission tomography (PET) quantification of tau protein aggregates in the brain with an ¹⁸F-labeled tracer called flortaucipir discriminated Alzheimer’s disease from other neurodegenerative diseases with strong though imperfect accuracy, a large, multicenter study found. {read more here}